Entrada Therapeutics (TRDA) Change in Taxes (2023 - 2025)
Entrada Therapeutics (TRDA) recorded quarterly Change in Taxes of -$620000.0 in Q4 2025, down 200.0% quarter-over-quarter from $620000.0 in Q3 2025, and up 60.86% on a YoY basis from -$385431.7 in Q4 2024.
Entrada Therapeutics (TRDA) Change in Taxes (2023 - 2025) Analysis & Trends
Entrada Therapeutics' Change in Taxes history runs 3 years deep, the most recent figure standing at -$620000.0 for Q4 2025.
- In Q4 2025, Change in Taxes rose 60.86% year-over-year to -$620000.0; the TTM figure through Mar 2026 stood at -$802000.0 (up 84.13% YoY), while the FY2025 annual figure was -$667000.0, up 80.13% from the prior year.
- Change in Taxes was -$620000.0 for Q4 2025 at Entrada Therapeutics, down from $620000.0 in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $7.4 million in Q2 2023 to a low of -$7.4 million in Q3 2023.
- Historically, Change in Taxes has averaged $0.0 across 3 years, with a median of -$620000.0 in 2025.
- The sharpest annual moves came in 2024 and 2025: Change in Taxes sank 139.36% in 2024, then soared 133.33% in 2025.
- A 3-year view of Change in Taxes shows it stood at $4.0 million in 2023, then tumbled by 139.36% to -$1.6 million in 2024, then surged by 60.86% to -$620000.0 in 2025.
- The last three Change in Taxes figures came in at -$620000.0 (Q4 2025), $620000.0 (Q3 2025), and -$802000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Entrada Therapeutics | 295.36 Mn | 295.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -620,000.00 |
| Dec 31, 2025 | -620,000.00 |
| Sep 30, 2025 | 620,000.00 |
| Sep 30, 2025 | 620,000.00 |
| Jun 30, 2025 | -802,000.00 |
| Jun 30, 2025 | -802,000.00 |
| Mar 31, 2025 | 135,000.00 |
| Mar 31, 2025 | 135,000.00 |
| Dec 31, 2024 | -1.58 Mn |
| Dec 31, 2024 | -1.58 Mn |
| Sep 30, 2024 | -1.86 Mn |
| Sep 30, 2024 | -1.86 Mn |
| Jun 30, 2024 | -1.74 Mn |
| Jun 30, 2024 | -1.74 Mn |
| Mar 31, 2024 | 1.83 Mn |
| Mar 31, 2024 | 1.83 Mn |
| Dec 31, 2023 | 4.02 Mn |
| Dec 31, 2023 | 4.02 Mn |
| Sep 30, 2023 | -7.36 Mn |
| Sep 30, 2023 | -7.36 Mn |